Rachel Simmermon
Pronouns: she/her
Research Mentor(s): Sherri Sheinfeld Gorin
Co-Presenter: Bolen, Nathan
Research Mentor School/College/Department: Department of Family Medicine / Medicine
Presentation Date: April 20
Presentation Type: Poster
Session: Session 5 – 3:40pm – 4:30 pm
Room: League Ballroom
Authors: Mehtab Bahl, Nathan Bolen, Rebecca Hyman, Rachel Simmermon, Caitlin Sohrabi, Sherri Sheinfeld Gorin
Presenter: 114
Abstract
Reducing HPV Vaccine Hesitancy in Rural Michigan Bahl, M., Bolen, N., Hyman, R., Simmermon, R., Sohrabi, C., Sheinfeld Gorin, S. Authors are listed in alphabetical order with the senior mentor listed last Corresponding author: Simmermon, R. Introduction: Hesitancy toward the human papillomavirus (HPV) vaccine in rural areas of Michigan is a large reason why uptake rates are low in those areas. Understanding the scientific findings that have already been uncovered on this subject is critical to directing efforts to increase vaccine uptake. We are conducting a systematic review to identify the best known strategies for combating hesitancy and increasing vaccine uptake moving forward. Methods: A systematic search across Medline, Embase, CINAHL, PsycInfo, Cochrane, Sociological Abstracts and Scopus databases was conducted by a University of Michigan Medical Librarian, resulting in 97 publications that met the pre-specified inclusion criteria for full-text review. Included publications are written in English and report measures regarding rural HPV vaccine uptake in the United States from 2010-2021. Publications that are incomplete or do not report measures, such as abstracts, protocols, commentaries, and reviews, were excluded. Using a standard codebook, we independently reviewed, coded and extracted study characteristics, and findings from each publication. Two team members are comparing their results. Disagreements are adjudicated by a third member to ensure reliability. Results: From the ten articles that this specific coder analyzed, the combined aim was to to understand how different demographic attributes and factors as well as interventions impact HPV vaccine uptake. Across the ten studies, 90% were observational studies compared to the 10% that were interventional. The most common population to study was patients, with an average sample size of patients was 36l, with a range of 579 participants. The second most popular population of interest was parents of children who are eligible to receive the HPV vaccine. The average sample size of the parental population was 4,046 and the range of sample sizes for that population 2,101. Other populations were also studied: clinics (average sample size: 115), local health departments (average sample size: 18), care providers (average sample sizes: 1437) and students (average sample size: 39). The primary outcome for 50% of these ten studies were HPV vaccination rates and 30% were specifically looking at rate of HPV vaccine initiation. Conclusion: Overall, these studies saw that provider recommendations strongly influence the vaccine uptake. It was also found that marginalized groups such as those living below the poverty line, members of the LGBTQIA+ community, racial minorities and rural citizens have lower vaccine uptake rates. So continued educational training on vaccine recommendations and administration are highly encouraged specifically for clinicians who serve these communities.
Biomedical Sciences, Public Health
